STAT6 and colorectal cancer: Patients with colorectal cancer exhibit a significant STAT6 activity in the colonic epithelium, and STAT6 expression is associated with lower survival rates, lymph node metastasis, changes in the epithelial barrier function, and alterations in the inflammatory response [9,10,11,12].